DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,993 filers reported holding DANAHER CORPORATION in Q3 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,373,250 | +3.4% | 37,780 | +0.0% | 0.14% | -1.4% |
| Q2 2023 | $9,063,074 | +175.0% | 37,763 | +188.8% | 0.14% | +132.8% |
| Q1 2023 | $3,295,073 | +109.6% | 13,074 | +110.5% | 0.06% | +60.5% |
| Q4 2022 | $1,571,723 | +1.6% | 6,211 | +3.7% | 0.04% | -20.8% |
| Q3 2022 | $1,547,000 | +2.6% | 5,991 | +0.7% | 0.05% | +4.3% |
| Q2 2022 | $1,508,000 | -16.2% | 5,949 | -3.1% | 0.05% | -22.0% |
| Q1 2022 | $1,800,000 | -11.3% | 6,138 | -0.5% | 0.06% | -10.6% |
| Q4 2021 | $2,029,000 | +10.7% | 6,166 | +2.4% | 0.07% | -1.5% |
| Q3 2021 | $1,833,000 | +30.1% | 6,021 | +14.7% | 0.07% | +17.5% |
| Q2 2021 | $1,409,000 | +19.5% | 5,251 | +0.2% | 0.06% | -9.5% |
| Q1 2021 | $1,179,000 | -0.9% | 5,240 | -2.2% | 0.06% | -8.7% |
| Q4 2020 | $1,190,000 | -1.7% | 5,358 | -4.6% | 0.07% | -16.9% |
| Q3 2020 | $1,210,000 | +23.2% | 5,619 | +1.2% | 0.08% | +12.2% |
| Q2 2020 | $982,000 | +28.2% | 5,554 | +0.4% | 0.07% | +1.4% |
| Q1 2020 | $766,000 | -2.5% | 5,531 | +8.1% | 0.07% | -24.0% |
| Q4 2019 | $786,000 | +16.8% | 5,118 | +9.8% | 0.10% | +3.2% |
| Q3 2019 | $673,000 | +1.7% | 4,663 | +0.6% | 0.09% | 0.0% |
| Q2 2019 | $662,000 | +6.3% | 4,633 | -1.8% | 0.09% | -20.5% |
| Q1 2019 | $623,000 | +36.0% | 4,718 | +6.3% | 0.12% | +21.9% |
| Q4 2018 | $458,000 | -7.5% | 4,440 | -2.5% | 0.10% | +7.9% |
| Q3 2018 | $495,000 | +10.7% | 4,553 | +0.5% | 0.09% | -6.3% |
| Q2 2018 | $447,000 | +0.7% | 4,530 | 0.0% | 0.10% | +1.1% |
| Q1 2018 | $444,000 | +6.7% | 4,530 | +1.1% | 0.09% | +6.8% |
| Q4 2017 | $416,000 | +8.3% | 4,480 | 0.0% | 0.09% | +2.3% |
| Q3 2017 | $384,000 | +1.6% | 4,480 | 0.0% | 0.09% | -3.4% |
| Q2 2017 | $378,000 | -1.3% | 4,480 | 0.0% | 0.09% | -6.3% |
| Q1 2017 | $383,000 | +9.7% | 4,480 | 0.0% | 0.10% | +1.1% |
| Q4 2016 | $349,000 | -2.0% | 4,480 | -1.4% | 0.09% | -4.1% |
| Q3 2016 | $356,000 | -21.8% | 4,545 | +0.9% | 0.10% | -24.6% |
| Q2 2016 | $455,000 | +6.6% | 4,504 | 0.0% | 0.13% | 0.0% |
| Q1 2016 | $427,000 | +9.5% | 4,504 | +7.1% | 0.13% | +6.6% |
| Q4 2015 | $390,000 | +5.1% | 4,204 | -3.5% | 0.12% | -8.3% |
| Q3 2015 | $371,000 | +2.2% | 4,355 | +2.7% | 0.13% | +9.0% |
| Q2 2015 | $363,000 | -0.3% | 4,240 | -1.2% | 0.12% | -5.4% |
| Q1 2015 | $364,000 | -1.1% | 4,290 | 0.0% | 0.13% | -7.2% |
| Q4 2014 | $368,000 | +14.6% | 4,290 | +1.7% | 0.14% | +2.2% |
| Q3 2014 | $321,000 | -5.0% | 4,220 | -1.6% | 0.14% | -6.8% |
| Q2 2014 | $338,000 | +7.0% | 4,290 | +1.7% | 0.15% | 0.0% |
| Q1 2014 | $316,000 | -3.1% | 4,220 | -0.0% | 0.15% | -8.8% |
| Q4 2013 | $326,000 | +8.7% | 4,222 | -2.5% | 0.16% | -1.8% |
| Q3 2013 | $300,000 | +8.7% | 4,330 | -0.7% | 0.16% | +1.9% |
| Q2 2013 | $276,000 | – | 4,360 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |